Cellectis SA (XPAR:ALCLS)
€ 1.48 -0.02 (-1.33%) Market Cap: 148.14 Mil Enterprise Value: -14.65 Mil PE Ratio: 0 PB Ratio: 1.29 GF Score: 44/100

Q1 2020 Cellectis SA Earnings Call Transcript

May 07, 2020 / 11:30AM GMT
Release Date Price: €12.96 (+0.78%)
Operator

Good morning, everyone, and welcome to the Cellectis' First Quarter 2020 Results Conference Call. (Operator Instructions) Please be aware that today's conference call is being recorded.

I'd now like to introduce the first speaker, Simon Harnest, Cellectis' Vice President of Corporate Strategy and Finance. You may begin.

Simon Harnest
Cellectis S.A. - VP of Corporate Strategy & Finance

Thank you, and welcome, everyone, to Cellectis' First Quarter 2020 Corporate Update and Financial Results Conference Call. Joining me on the call today with prepared remarks are Dr. André Choulika, our Chairman and Chief Executive Officer; Dr. Carrie Brownstein, Chief Medical Officer; Bill Monteith, Executive Vice President, Technical Operations; and Eric Dutang, our Chief Financial Officer.

Yesterday evening, Cellectis issued a press release reporting our financial results for the first quarter ended March 31, 2020. The press release is available on our website at cellectis.com.

As a reminder, we will make forward-looking statements regarding

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot